Guido Boehmelt

2.6k total citations
23 papers, 1.1k citations indexed

About

Guido Boehmelt is a scholar working on Molecular Biology, Cell Biology and Oncology. According to data from OpenAlex, Guido Boehmelt has authored 23 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Cell Biology and 6 papers in Oncology. Recurrent topics in Guido Boehmelt's work include Cancer-related Molecular Pathways (5 papers), Microtubule and mitosis dynamics (4 papers) and Ubiquitin and proteasome pathways (4 papers). Guido Boehmelt is often cited by papers focused on Cancer-related Molecular Pathways (5 papers), Microtubule and mitosis dynamics (4 papers) and Ubiquitin and proteasome pathways (4 papers). Guido Boehmelt collaborates with scholars based in Austria, United States and Germany. Guido Boehmelt's co-authors include Peter Mayinger, Norman N. Iscove, Hartmut Beug, Martin Zenke, Paula J. Enrietto, Tak W. Mak, Andreas Knödler, Teresa Nicolson, Anastasia Blagoveshchenskaya and Gerlinde Konrad and has published in prestigious journals such as Cell, Journal of Biological Chemistry and Nature Genetics.

In The Last Decade

Guido Boehmelt

23 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guido Boehmelt Austria 17 825 253 252 212 106 23 1.1k
Xiao-Jia Chang United States 7 680 0.8× 264 1.0× 371 1.5× 109 0.5× 144 1.4× 10 1.2k
K Zenita Japan 14 897 1.1× 191 0.8× 358 1.4× 142 0.7× 78 0.7× 20 1.1k
Teruo Miyauchi Japan 13 816 1.0× 150 0.6× 368 1.5× 189 0.9× 60 0.6× 17 1.0k
Lynn Bonham United States 19 536 0.6× 77 0.3× 430 1.7× 174 0.8× 107 1.0× 33 1.2k
Laurence Covassin United States 13 683 0.8× 380 1.5× 406 1.6× 246 1.2× 96 0.9× 14 1.3k
T Miyagi Japan 14 940 1.1× 285 1.1× 392 1.6× 100 0.5× 109 1.0× 31 1.1k
Lucy MacCarthy‐Morrogh United Kingdom 14 503 0.6× 344 1.4× 188 0.7× 216 1.0× 100 0.9× 17 962
Katayoon H. Emami United States 9 1.2k 1.5× 209 0.8× 118 0.5× 331 1.6× 119 1.1× 10 1.4k
Darwin Asa United States 8 700 0.8× 222 0.9× 355 1.4× 112 0.5× 147 1.4× 8 1.2k
Mala Mani United States 11 1.1k 1.3× 400 1.6× 132 0.5× 413 1.9× 105 1.0× 15 1.4k

Countries citing papers authored by Guido Boehmelt

Since Specialization
Citations

This map shows the geographic impact of Guido Boehmelt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guido Boehmelt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guido Boehmelt more than expected).

Fields of papers citing papers by Guido Boehmelt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guido Boehmelt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guido Boehmelt. The network helps show where Guido Boehmelt may publish in the future.

Co-authorship network of co-authors of Guido Boehmelt

This figure shows the co-authorship network connecting the top 25 collaborators of Guido Boehmelt. A scholar is included among the top collaborators of Guido Boehmelt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guido Boehmelt. Guido Boehmelt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jackson, Mark, Niousha Ahmari, Jianqiang Wu, et al.. (2023). Combining SOS1 and MEK Inhibitors in a Murine Model of Plexiform Neurofibroma Results in Tumor Shrinkage. Journal of Pharmacology and Experimental Therapeutics. 385(2). 106–116. 8 indexed citations
2.
Schick, Sandra, André F. Rendeiro, Anna Ringler, et al.. (2019). Systematic characterization of BAF mutations provides insights into intracomplex synthetic lethalities in human cancers. Nature Genetics. 51(9). 1399–1410. 91 indexed citations
3.
Teyra, Joan, Alex U. Singer, Frank W. Schmitges, et al.. (2019). Structural and Functional Characterization of Ubiquitin Variant Inhibitors of USP15. Structure. 27(4). 590–605.e5. 43 indexed citations
4.
Leźnicki, Paweł, N. Jayaprakash, Gerd Bader, et al.. (2018). Expansion of DUB functionality generated by alternative isoforms – USP35, a case study. Journal of Cell Science. 131(10). 26 indexed citations
5.
Sini, Patrizia, Ulrich Gürtler, Stephan K. Zahn, et al.. (2016). Pharmacological Profile of BI 847325, an Orally Bioavailable, ATP-Competitive Inhibitor of MEK and Aurora Kinases. Molecular Cancer Therapeutics. 15(10). 2388–2398. 28 indexed citations
6.
Bultinck, Jennyfer, Kevin Myant, Laura A. Jaenicke, et al.. (2014). Tumor cell‐specific inhibition of MYC function using small molecule inhibitors of the HUWE 1 ubiquitin ligase. EMBO Molecular Medicine. 6(12). 1525–1541. 92 indexed citations
7.
Sini, Patrizia, Ulrich Gürtler, Stephan K. Zahn, et al.. (2012). Abstract 1919: Pharmacological characterization of BI 847325, a dual inhibitor of MEK and Aurora kinases. Cancer Research. 72(8_Supplement). 1919–1919. 1 indexed citations
8.
Gürtler, Ulrich, Ulrike Tontsch-Grunt, Marc A. Jarvis, et al.. (2010). Effect of BI 811283, a novel inhibitor of Aurora B kinase, on tumor senescence and apoptosis.. Journal of Clinical Oncology. 28(15_suppl). e13632–e13632. 12 indexed citations
9.
Huber, Margit A., Helena J. Maier, Guido Boehmelt, et al.. (2010). BI 5700, a Selective Chemical Inhibitor of I B Kinase 2, Specifically Suppresses Epithelial-Mesenchymal Transition and Metastasis in Mouse Models of Tumor Progression. Genes & Cancer. 1(2). 101–114. 15 indexed citations
10.
Tontsch-Grunt, Ulrike, Ulrich Gürtler, Stephan K. Zahn, et al.. (2010). Abstract 1080: Molecular and cellular pharmacology of BI 811283, a potent inhibitor of Aurora B kinase. Cancer Research. 70(8_Supplement). 1080–1080. 4 indexed citations
11.
Blagoveshchenskaya, Anastasia, et al.. (2008). Integration of Golgi trafficking and growth factor signaling by the lipid phosphatase SAC1. The Journal of Cell Biology. 180(4). 803–812. 128 indexed citations
12.
Konrad, Gerlinde, et al.. (2003). The Human Phosphatidylinositol Phosphatase SAC1 Interacts with the Coatomer I Complex. Journal of Biological Chemistry. 278(52). 52689–52699. 82 indexed citations
13.
Briegel, Karoline J., et al.. (2000). Dendritic Cells Conditionally Transformed by v-relER Oncogene Express Lymphoid Marker Genes. Immunobiology. 202(4). 394–407. 3 indexed citations
14.
Boehmelt, Guido, Irene Fialka, Michael D. McGinley, et al.. (2000). Cloning and Characterization of the Murine Glucosamine-6-phosphate Acetyltransferase EMeg32. Journal of Biological Chemistry. 275(17). 12821–12832. 46 indexed citations
15.
Boehmelt, Guido, Andrew Wakeham, Andrew Elia, et al.. (2000). Decreased UDP-GlcNAc levels abrogate proliferation control in EMeg32-deficient cells. The EMBO Journal. 19(19). 5092–5104. 139 indexed citations
16.
17.
Boehmelt, Guido, et al.. (1995). Dendritic cell progenitor is transformed by a conditional v-Rel estrogen receptor fusion protein v-ReIER. Cell. 80(2). 341–352. 52 indexed citations
18.
Brady, Gerard, Filio Billia, Jennifer J. Knox, et al.. (1995). Analysis of gene expression in a complex differentiation hierarchy by global amplification of cDNA from single cells. Current Biology. 5(8). 909–922. 147 indexed citations
19.
Boehmelt, Guido, Eugen Ulrich, R Kurzbauer, et al.. (1994). Structure and expression of the chicken retinoblastoma gene.. PubMed. 5(2). 221–30. 21 indexed citations
20.
Boehmelt, Guido, Amy K. Walker, N Kabrun, et al.. (1992). Hormone-regulated v-rel estrogen receptor fusion protein: reversible induction of cell transformation and cellular gene expression.. The EMBO Journal. 11(12). 4641–4652. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiao-Jia Chang Breakdown of academic impact, for papers by K Zenita Breakdown of academic impact, for papers by Teruo Miyauchi Breakdown of academic impact, for papers by Lynn Bonham Breakdown of academic impact, for papers by Laurence Covassin Breakdown of academic impact, for papers by T Miyagi Breakdown of academic impact, for papers by Lucy MacCarthy‐Morrogh Breakdown of academic impact, for papers by Katayoon H. Emami Breakdown of academic impact, for papers by Darwin Asa Breakdown of academic impact, for papers by Mala Mani
Rankless by CCL
2026